ATM and PRDM9 regulate SPO11-bound recombination intermediates during meiosis

Jacob Paiano, Wei Wu, Shintaro Yamada, Nicholas Sciascia, Elsa Callen, Ana Paola Cotrim, Rajashree A. Deshpande, Yaakov Maman, Amanda Day, Tanya T. Paull, André Nussenzweig

Research output: Contribution to journalArticlepeer-review

74 Scopus citations

Abstract

Meiotic recombination is initiated by SPO11-induced double-strand breaks (DSBs). In most mammals, the methyltransferase PRDM9 guides SPO11 targeting, and the ATM kinase controls meiotic DSB numbers. Following MRE11 nuclease removal of SPO11, the DSB is resected and loaded with DMC1 filaments for homolog invasion. Here, we demonstrate the direct detection of meiotic DSBs and resection using END-seq on mouse spermatocytes with low sample input. We find that DMC1 limits both minimum and maximum resection lengths, whereas 53BP1, BRCA1 and EXO1 play surprisingly minimal roles. Through enzymatic modifications to END-seq, we identify a SPO11-bound meiotic recombination intermediate (SPO11-RI) present at all hotspots. We propose that SPO11-RI forms because chromatin-bound PRDM9 asymmetrically blocks MRE11 from releasing SPO11. In Atm–/– spermatocytes, trapped SPO11 cleavage complexes accumulate due to defective MRE11 initiation of resection. Thus, in addition to governing SPO11 breakage, ATM and PRDM9 are critical local regulators of mammalian SPO11 processing.

Original languageEnglish
Article number857
JournalNature Communications
Volume11
Issue number1
DOIs
StatePublished - 12 Feb 2020
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2020, This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Funding

We thank Todd Macfarlan, Mohamed Mahgoub, Michael Lichten, and Kevin Brick for comments on the manuscript; Francesca Cole, Todd Macfarlan, Mohamed Mahgoub, Scott Keeney, Agnieszka Lukaszewicz, Maria Jasin, Anjali Hinch, and Petko Petkov for sharing unpublished data and insightful suggestions; Petko Petkov for PRDM9 KO mice and Scott Keeney for DMC1 knockout mice; R. Daniel Camerini-Otero and Florencia Pratto for HOP2 KO mice; Keith W. Caldecott for purified human TDP2; and Jennifer Wise and Kelly Smith for assistance with animal work. The A.N. laboratory is supported by the Intramural Research Program of the NIH, an Ellison Medical Foundation Senior Scholar in Aging Award (AG-SS-2633-11), the Department of Defense Idea Expansion (W81XWH-15-2-006) and Breakthrough (W81XWH-16-1-599) Awards, the Alex Lemonade Stand Foundation Award, and an NIH Intramural FLEX Award.

FundersFunder number
Department of Defense Idea ExpansionW81XWH-15-2-006, W81XWH-16-1-599
National Institutes of Health
National Cancer InstituteP30CA008748
Ellison Medical FoundationAG-SS-2633-11
Alex's Lemonade Stand Foundation for Childhood Cancer

    Fingerprint

    Dive into the research topics of 'ATM and PRDM9 regulate SPO11-bound recombination intermediates during meiosis'. Together they form a unique fingerprint.

    Cite this